Additional eight mutations that were significantly enriched in rHL/prHL affect genes that were previously associated with the progression of other lymphoma subtypes (e.g., PDGFRB, KAT6A, HGF, EPHB1, NSD2, PMS2) [30, 34–36]. This evidence concerns the gene EPHB1 and lymphoma.